Rezultati

eNauka >  Results >  Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer
Title: Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer
Authors: Domine, Gomez Manuel; Csoszi, Tibor; Jaal, Jana; Kudaba, Iveta; Nikolov, Krassimir; Radosavljevic, Davorin Z; Xiao, Jie; Horton, Janet K; Malik, Rajesh K; Subramanian, Janakiraman
Issue Date: 2021
Publication: INTERNATIONAL JOURNAL OF CANCER
ISSN: 0020-7136 International Journal of Cancer Search Idenfier
Type: Article
Collation: vol. 149 br. 7 str. 1463-1472
DOI: 10.1002/ijc.33705
WoS-ID: 000671588700001
Scopus-ID: 2-s2.0-85110046493
PMID: 34109630
PMCID: PMC8457063
URI: https://enauka.gov.rs/handle/123456789/801876
Project: G1 Therapeutics, Inc.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

13
SCOPUSTM
5
PubMed CentralTM
4
OpenCitations
12
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.